Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

334
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
334
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice.

American journal of physiology. Regulatory, integrative and comparative physiology·2012
Same author

Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population.

Asian Pacific journal of cancer prevention : APJCP·2012
Same author

AKT Activation by Pdcd4 Knockdown Up-Regulates Cyclin D1 Expression and Promotes Cell Proliferation.

Genes & cancer·2012
Same author

Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

Progress in neurobiology·2012
Same author

Two-step stacking by sweeping and micelle to solvent stacking using a long-chain cationic ionic liquid surfactant.

Journal of separation science·2012
Same author

DNA repair gene deficiency does not predispose human bronchial epithelial cells to benzo(a)pyrene-induced cell transformation.

Toxicology in vitro : an international journal published in association with BIBRA·2012

Related Experiment Video

Updated: Jan 11, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

989

Two Cases of Significant Coagulation Dysfunction Caused by Sulperazon.

Qing Wang, Qiuli He, Xiuping Xu

    Clinical Laboratory
    |November 12, 2025
    PubMed
    Summary

    Sulperazon, an antibiotic, can cause vitamin K deficiency leading to prolonged prothrombin time (PT). Clinicians should monitor coagulation function during long-term use and consider vitamin K1 or plasma transfusions if needed.

    Area of Science:

    • Pharmacology
    • Clinical Medicine
    • Hematology

    Background:

    • Sulperazon, a combination of cefoperazone and sulbactam sodium, is widely used for bacterial infections.
    • Adverse reactions to Sulperazon typically include allergic responses, gastrointestinal issues, and liver dysfunction.
    • Coagulation abnormalities are a rare but significant adverse effect of Sulperazon, often overlooked.

    More Related Videos

    Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
    06:35

    Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

    Published on: March 29, 2024

    1.1K
    Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
    06:23

    Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

    Published on: August 4, 2018

    9.2K

    Related Experiment Videos

    Last Updated: Jan 11, 2026

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
    04:37

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

    Published on: May 23, 2025

    989
    Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
    06:35

    Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

    Published on: March 29, 2024

    1.1K
    Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
    06:23

    Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

    Published on: August 4, 2018

    9.2K